🩸 Restless Legs Syndrome & Iron Deficiency Simulator
A model linking low ferritin levels with restless legs syndrome through iron deficiency in the basal ganglia and symptom improvement with iron therapy.
Low Serum Ferritin as the Root Trigger
Peripheral iron stores set the ceiling for brain iron delivery.
- <50: Ferritin threshold (ng/mL RLS risk zone)
- 30–300: Normal range (ng/mL typical adult)
- ~25%: Prevalence link (RLS patients iron deficient)
- Serum ferritin: Screening test (first-line lab check)
Peripheral iron status
Placeholder: low ferritin reflects depleted total-body iron stores.
Brain Iron Depletion in the Basal Ganglia
Regional brain iron tracks peripheral ferritin with a lag.
- Substantia nigra: Key region (iron-rich dopaminergic hub)
- MRI T2*: Imaging marker (detects regional iron loss)
- Transferrin: Transport protein (crosses blood-brain barrier)
- Reduced: CSF ferritin (in RLS patients)
Regional brain iron
Placeholder: basal ganglia iron pools shrink under systemic deficiency.
Iron-Dependent Dopamine Synthesis Falters
Iron is a cofactor for the dopamine-synthesis enzyme pathway.
- Tyrosine hydroxylase: Cofactor enzyme (iron-dependent step)
- Evening worsening: Circadian pattern (matches RLS symptom timing)
- D2 downregulation: Receptor change (postsynaptic adaptation)
- Dopamine agonists: Treatment clue (partially relieve symptoms)
Dopamine pathway disruption
Placeholder: reduced iron impairs dopaminergic neurotransmission.
From Dysfunction to Restless Legs Sensation
Circuit imbalance produces the urge to move the legs.
- Urge to move: Core symptom (worse at rest, evening)
- Movement relieves: Relief pattern (temporary symptom relief)
- Frequent: Sleep disruption (periodic limb movements)
- Clinical criteria: Diagnosis basis (IRLSSG four-point checklist)
Symptom expression
Placeholder: restlessness pulses correlate with dopaminergic deficit severity.
Symptom Improvement with Iron Repletion
Restoring ferritin gradually restores basal ganglia function.
- Oral/IV iron: Therapy route (depends on severity)
- Weeks: Response time (gradual symptom easing)
- >75: Target ferritin (ng/mL treatment goal)
- Reduced severity: Outcome (in responders)
Therapeutic response
Placeholder: iron therapy over weeks lowers RLS severity scores.
Placeholder: sustained iron repletion improves sleep and symptom scores.
A model linking low ferritin levels with restless legs syndrome through iron deficiency in the basal ganglia and symptom improvement with iron therapy.
2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install